Lancet 375:22342243 Marre M, Shaw J, Brndle M et al (2009) Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with type 2 diabetes (LEAD-1 SU)
This might allow fine-tuning the benefit-to-side-effect ratio
Tuy nhin, nu bn c tin s d ng hoc nhy cm vi bt k th nh phn n o ca sn phm, c th gp phn ng nh nh kch ng d d y
Adverse effects of Glitazars may include myopathy and muscle catabolism, fluid retention, renal damage, weight gain, peripheral oedema and early indications of an increased cardiovascular risk 16
Programs were reviewed for evidencebased guidance, clarity of education, and how well the tools (apps, coaching, meal plans) help people build lasting habits
When laser lipo eliminates these cells, your body doesnt create new ones to replace them